Midven backs Alzheimer’s research
Cytox, a university spin-out that creates diagnostics tests and therapeutic cures for Alzheimer’s disease, has raised £1.25 million from Midven, NESTA and angel investors including members of Cambridge Angels and Cogent Lifesciences.
News